42nd week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160303149 | SWEET TASTE RECEPTOR ANTAGONIST COMPOSITIONS | 2016-10-20 |
20160303150 | DEUTERATED TREHALOSE FORMULATIONS AND USES THEREOF | 2016-10-20 |
20160303151 | Topical Composition of Ivermectin | 2016-10-20 |
20160303152 | Topical Composition of Ivermectin | 2016-10-20 |
20160303153 | Topical Lotion Composition Comprising Ivermectin | 2016-10-20 |
20160303154 | Topical Gel Composition Comprising Ivermectin | 2016-10-20 |
20160303155 | Topical Solution Composition Comprising Ivermectin | 2016-10-20 |
20160303156 | PHARMACEUTICAL COMPOSITION COMPRISING NARINGIN AND LEVOCETIRIZINE HYDROCHLORIDE, AND PREPARATIONS THEREOF | 2016-10-20 |
20160303157 | METHOD FOR PREPARING AN ANTHELMINTIC COMPOSITION, ANTHELMINTIC COMPOSITION, VETERINARY TREATMENT METHOD AND ANTHELMINTIC TREATMENT METHOD | 2016-10-20 |
20160303158 | NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) | 2016-10-20 |
20160303159 | A Pyrimidine Derivative and a Fatty Acid Source for Use in the Treatment of Constipation | 2016-10-20 |
20160303160 | Combinatorial Approach To Treating Alzheimer's Disease Cross-Reference To Related Applications | 2016-10-20 |
20160303161 | COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING LOW MOLECULAR WEIGHT HYALURONIC ACID AND ASTAXANTHIN | 2016-10-20 |
20160303162 | COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING LOW MOLECULAR WEIGHT HYALURONIC ACID AND ASTAXANTHIN | 2016-10-20 |
20160303163 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IRON DEFICIENCY, COMPRISING IRON OXIDE NANOPARTICLES | 2016-10-20 |
20160303164 | Composition Useful for Promoting Female Fertility | 2016-10-20 |
20160303165 | HUCBC TREATMENT OF AMYLOID-ASSOCIATED DISEASE | 2016-10-20 |
20160303166 | HEPATIC ARTERIAL INFUSION OF CAR-T CELLS | 2016-10-20 |
20160303167 | CARTILAGE REGENERATION-PROMOTING AGENT | 2016-10-20 |
20160303168 | METHOD FOR ENHANCING THERAPEUTIC EFFECT OF STEM CELLS | 2016-10-20 |
20160303169 | SKELETAL MUSCLE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF | 2016-10-20 |
20160303170 | METHODS AND MATERIALS FOR REDUCING VENOUS NEOINTIMAL HYPERPLASIA OF AN ARTERIOVENOUS FISTULA OR GRAFT | 2016-10-20 |
20160303171 | UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS | 2016-10-20 |
20160303172 | MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO CHEMOTHERAPY, AND USE OF MICROBIAL MODULATORS (PRE-, PRO- OR SYNBIOTICS) FOR IMPROVING THE EFFICACY OF A CANCER TREATMENT | 2016-10-20 |
20160303173 | METHOD FOR PREVENTING OR TREATING FUNCTIONAL GASTROINTESTINAL DISORDER BY LACTIC ACID BACTERIUM | 2016-10-20 |
20160303174 | STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS | 2016-10-20 |
20160303175 | Cancer Treatment Using Viruses and Camptothecins | 2016-10-20 |
20160303176 | NUTRITIONAL SUPPLEMENT | 2016-10-20 |
20160303177 | NUTRITIONAL SUPPLEMENT | 2016-10-20 |
20160303178 | PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING THE SAME AND USE THEREOF | 2016-10-20 |
20160303179 | PLANT-BASED COMPOSITION FOR USE IN THE TREATMENT OF COUGH | 2016-10-20 |
20160303180 | HERBAL FORMULATIONS | 2016-10-20 |
20160303181 | SYNERGISTIC COMBINATION OF ALANINE-GLUTAMINE, HYALURONIC ACID AND OAT EXTRACT AND THE USE THEREOF IN A COMPOSITION INTENDED FOR HEALING WOUNDS AND REPAIRING SKIN LESIONS | 2016-10-20 |
20160303182 | USE OF PEPTIDES IN ANTIBIOTIC RESISTANCE | 2016-10-20 |
20160303183 | POLYPEPTIDE, NUCLEOTIDE SEQUENCE THEREOF, AND METHOD FOR USING THE SAME FOR PREVENTING DNA SYNTHESIS AND INHIBITING CELL PROLIFERATION | 2016-10-20 |
20160303184 | VANCOMYCIN-SUGAR CONJUGATES AND USES THEREOF | 2016-10-20 |
20160303185 | METHODS AND DEVICES FOR DESMOPRESSIN DRUG DELIVERY | 2016-10-20 |
20160303186 | CYCLIC-GLUR6 ANALOGS, METHODS OF TREATMENT AND USE | 2016-10-20 |
20160303187 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | 2016-10-20 |
20160303188 | METHOD FOR FORMING AN IMMUNE-TOLERANT SITE AND METHOD FOR ATTRACTING IMMUNOSUPPRESSIVE CELLS | 2016-10-20 |
20160303189 | Applications of Recombined Ganoderma Lucidum Immunoregulation Protein in Preparing Drugs for Treating Tissue Fibrosis | 2016-10-20 |
20160303190 | METHOD FOR TREATMENT OF GASTRIC ULCERS | 2016-10-20 |
20160303191 | COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS | 2016-10-20 |
20160303192 | OPTICALLY-CONTROLLED CNS DYSFUNCTION | 2016-10-20 |
20160303193 | INHIBITION OF COLLAGEN SYNTHESIS | 2016-10-20 |
20160303194 | Compositions And Method For Treatment Of Inflammatory Bowel Disease | 2016-10-20 |
20160303195 | METHODS FOR TREATING INFLAMMATORY DISORDERS AND TRAUMATIC BRAIN INJURY USING STABILIZED NON-HEMATOPOIETIC EPO SHORT PEPTIDES | 2016-10-20 |
20160303196 | USE OF CCL1 IN THERAPY | 2016-10-20 |
20160303197 | METHODS FOR REPAIRING TISSUE DAMAGE USING PROTEASE-RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1 | 2016-10-20 |
20160303198 | METHOD OF IMMUNOTHERAPY FOR TREATMENT OF HUMAN PAPILLOMAVIRUS INFECTION | 2016-10-20 |
20160303199 | USE OF URODILATIN FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CARDIOVASCULAR, RENAL, PULMONARY AND NEURONAL SYNDROMES WHILE AVOIDING A REBOUND | 2016-10-20 |
20160303200 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF METASTATIC CANCER | 2016-10-20 |
20160303201 | LIQUID FORMULATION OF FSH | 2016-10-20 |
20160303202 | LIQUID FORMULATION OF FSH | 2016-10-20 |
20160303203 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS | 2016-10-20 |
20160303204 | METHOD FOR TREATING SYSTEMIC DNA MUTATION DISEASE | 2016-10-20 |
20160303205 | Combination Therapies for Lysosomal Storage Diseases | 2016-10-20 |
20160303206 | PHARMACEUTICAL OR NUTRITIONAL COMPOSITIONS CONTAINING GALACTOSIDASE, AND THEIR USE | 2016-10-20 |
20160303207 | BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY | 2016-10-20 |
20160303208 | METHOD FOR TREATING AMYLOID DISEASE | 2016-10-20 |
20160303209 | Autoimmune Antigens and Cancer | 2016-10-20 |
20160303210 | COMPOSITION FOR TREATING PROSTATE CANCER (PCa) | 2016-10-20 |
20160303211 | DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a) | 2016-10-20 |
20160303212 | Interferon- Production Modulating Listeria Strains and Methods for Using Same | 2016-10-20 |
20160303213 | PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS BY GLYCOPROTEIN VACCINES SYNTHESIZED IN ESCHERICHIA COLI | 2016-10-20 |
20160303214 | PROCESS FOR DETERGENT-FREE PRODUCTION OF OUTER MEMBRANE VESICLES OF A GRAM-NEGATIVE BACTERIUM | 2016-10-20 |
20160303215 | INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION | 2016-10-20 |
20160303216 | BORDETELLA PERTUSSIS IMMUNOGENIC VACCINE COMPOSITIONS | 2016-10-20 |
20160303217 | Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins | 2016-10-20 |
20160303218 | VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2016-10-20 |
20160303219 | Swine Vaccine Against PRRS and Lawsonia Intracellularis | 2016-10-20 |
20160303220 | Immortalized Porcine Alveolar Macrophage | 2016-10-20 |
20160303221 | VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE | 2016-10-20 |
20160303222 | Compositions and Methods for Vaccination Against Influenza a Virus | 2016-10-20 |
20160303223 | UNIVERSAL VIRUS-LIKE PARTICLE (VLP) INFLUENZA VACCINES | 2016-10-20 |
20160303224 | EPSTEIN-BARR VIRUS VACCINES | 2016-10-20 |
20160303225 | HUMAN HERPESVIRUS TRIMERIC GLYCOPROTEIN B, PROTEIN COMPLEXES COMPRISING TRIMERIC gB AND THEIR USE AS VACCINES | 2016-10-20 |
20160303226 | HEAT-TREATED FORMULATION OF BIFIDOBACTERIUM LACTIS NCC 2818 REDUCES ALLERGIC MANIFESTATIONS | 2016-10-20 |
20160303227 | ANTI-GANGLIOSIDE COMPOUND FOR TARGETING CANCER AND GENERATING ANTIBODIES | 2016-10-20 |
20160303228 | SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION | 2016-10-20 |
20160303229 | METHODS OF TREATING NECROTIZING ENTEROCOLITIS BY ADMINISTERING NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS,TLR9 AGONISTS AND TLR4 ANTAGONISTS | 2016-10-20 |
20160303230 | CHIMERIC ANTIGEN RECEPTOR FOR BISPECIFIC ACTIVATION AND TARGETING OF T LYMPHOCYTES | 2016-10-20 |
20160303231 | TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR | 2016-10-20 |
20160303232 | COMBINATION TREATMENTS WITH SERIBANTUMAB | 2016-10-20 |
20160303233 | Stable Aqueous Formulations of Adalimumab | 2016-10-20 |
20160303234 | Stable Aqueous Formulations of Adalimumab | 2016-10-20 |
20160303235 | Stable Aqueous Formulations of Adalimumab | 2016-10-20 |
20160303236 | REGIONALLY ACTIVATED DRUG DELIVERY NANOPARTICLES | 2016-10-20 |
20160303237 | PHOTODYNAMIC THERAPY FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION USING CHITOSAN AND TETRACYCLINE | 2016-10-20 |
20160303238 | LIQUID FORMULATION OF FSH | 2016-10-20 |
20160303239 | Sprayable Topical Carrier and Composition Comprising Phosphatidylcholine | 2016-10-20 |
20160303240 | INJECTIBLE AGENT AND DEPOT FORMATION METHOD | 2016-10-20 |
20160303241 | ROS-DEGRADEABLE HYDROGELS | 2016-10-20 |
20160303242 | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same | 2016-10-20 |
20160303243 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | 2016-10-20 |
20160303244 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | 2016-10-20 |
20160303245 | FATTY ACID DERIVATIVES OF DIMERIC INHIBITORS OF PSD-95 | 2016-10-20 |
20160303246 | NOVEL ANTIMICROBIAL AGENTS | 2016-10-20 |
20160303247 | Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods | 2016-10-20 |
20160303248 | Method for Thioether Conjugation of Proteins | 2016-10-20 |